Other functions support for the director's consumer liaison group meeting - january 2013.

Ended Awarded Last action

Contract number
HHSN26100009
Awardee
Awarding agency
Obligated
$25,897

Award facts

Contract value 100% obligated
$25,896.96 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 4 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 · Support for the director's consumer liaison group meeting - january 2013. -$103
Original award $26,000

About this award

The National Cancer Institute issued a delivery order to Palladian Partners, Inc. on September 21, 2012, with a ceiling value of $25,896.96 for support of the Director's Consumer Liaison Group meeting in January 2013.

Place of performance is Bethesda, MD 20892. The order was firm fixed price with an ultimate completion date of September 19, 2017. No set-aside was used.

Quick answers

Who was awarded contract HHSN26100009?

HHSN26100009 was awarded to Palladian Partners, Inc. by National Cancer Institute (National Institutes of Health) on September 21, 2012.

How much is contract HHSN26100009 worth?

The government has obligated $25,897 on HHSN26100009.

Is contract HHSN26100009 an order under another contract?

Yes. HHSN26100009 is a delivery order under HHSN261200700041I, an indefinite delivery contract.

Was contract HHSN26100009 competed?

The extent of competition for HHSN26100009 was competed under sap. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award